Literature DB >> 10562269

Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine.

W Shen1, K Asai, M Uechi, M A Mathier, R P Shannon, S F Vatner, J S Ingwall.   

Abstract

BACKGROUND: Whether myocardial ATP content falls in heart failure is a long-standing and controversial issue. The mechanism(s) to explain any decrease in ATP content during heart failure have not been identified. METHODS AND
RESULTS: Cardiac dysfunction, heart failure, and a prolonged steady state of heart failure were induced by chronic right ventricular pacing for 1 to 2 weeks, 3 to 4 weeks, and 7 to 9 weeks in dogs. Cardiac function and myocardial O(2) consumption (Mf1.gif" BORDER="0">O(2)) were measured with the dogs in the conscious state. ATP, total purine, and creatine were measured in biopsy specimens obtained at each stage. ATP and the total purine pool progressively fell at rates of 0.12 and 0.15 nmol. mg protein(-1). d(-1), despite an increase in Mf1.gif" BORDER="0">O(2). The rate of loss of creatine was 1.06 nmol. mg protein(-1). d(-1), 7 times faster than the depletion of total purine.
CONCLUSIONS: (1) ATP contents progressively decreased during heart failure as a result of a loss of the total purine pool. The loss of purines may be due to inhibition of de novo purine synthesis. (2) Loss of creatine is an early marker of heart failure and may serve as a compensatory mechanism minimizing the reduction of the total purine pool in the failing heart.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10562269     DOI: 10.1161/01.cir.100.20.2113

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

1.  Impaired ATP kinetics in failing in vivo mouse heart.

Authors:  Ashish Gupta; Vadappuram P Chacko; Michael Schär; Ashwin Akki; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2010-10-06       Impact factor: 7.792

Review 2.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

Review 3.  Mitochondrial centrality in heart failure.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2008-01-05       Impact factor: 4.214

Review 4.  New aspects of impaired mitochondrial function in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 5.  Energy metabolism in heart failure and remodelling.

Authors:  Joanne S Ingwall
Journal:  Cardiovasc Res       Date:  2008-11-05       Impact factor: 10.787

6.  Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.

Authors:  Glenn A Hirsch; Paul A Bottomley; Gary Gerstenblith; Robert G Weiss
Journal:  J Am Coll Cardiol       Date:  2012-02-28       Impact factor: 24.094

Review 7.  Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.

Authors:  Andrew N Carley; Heinrich Taegtmeyer; E Douglas Lewandowski
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

8.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

9.  Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance.

Authors:  Ashish Gupta; V P Chacko; Robert G Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

10.  Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling.

Authors:  Zhong Gao; Andreas S Barth; Deborah DiSilvestre; Fadi G Akar; Yanli Tian; Antti Tanskanen; David A Kass; Raimond L Winslow; Gordon F Tomaselli
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.